[1]
Saha, S. and Saha, S. 2020. A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients. International Journal of Health Sciences. 14, 2 (Feb. 2020).